Mentat®, an indigenous, ayurvedic preparation containing Bacopa monnieri, Centella asiatica, Cithania somnifera, Evolvulus alsinoide, and Cardostachys jatamans , were tested for its efficacy in patients suffering from functional impairment following stroke. Twenty-four patients participated in the study. Thirteen patients received Mentat®, and eleven patients received placebo for a 12-week period. The Mentat® patients had better EMG (electromyographic) responses compared to the placebo group after 12 weeks.
